StemLifeLine
StemLifeLine’s goal is to offer thousands of people who have undergone in vitro fertilization an option that they did not have until now: To turn their remaining embryos into family-owned stem cell lines.

StemLifeLine is the first life sciences company to offer individuals who have undergone in vitro fertilization a unique option to develop stem cell lines from their remaining stored embryos. We can help transform these embryos into individual stem cell lines that our clients may one day use to create stem cell therapies for themselves and their families.

We founded StemLifeLine to meet the needs of couples that have undergone in vitro fertilization. These couples, along with numerous clinicians and individuals that interact regularly with fertility patients, approached us with a request for increased options for their embryos remaining from in vitro fertilization. It is for them that we are offering this novel service. We believe that in the not so distant future, our clients will achieve profound therapeutic benefits from therapies created from their stem cell lines.

Think of our service as investment for the future. With more than a decade of scientific research supporting the future use of embryonic stem cells and several therapies currently under development, therapies based on your family’s genetically-related stem cell line may be in future available for you and your family.